Cytolethal distending toxin (CDT) is a heterotrimeric protein toxin produced by several pathogenic bacteria. CDT activity is dependent on the expression of three closely linked genes, cdtA, cdtB, and cdtC, encoding proteins with molecular masses of approximately 27, 29, and 20 kDa, respectively (1, 9, 19, 23, 25, 28) . Several reports show that the CDT holotoxin is composed of all three proteins bound together to from a tripartite complex (9, 13, 15, 22, 24) . Considerable evidence supports the notion that CdtB is the biologically active subunit. The direct introduction or expression of CdtB in mammalian cells results in all the cytotoxic effects associated with the CDT holotoxin (7, 10, 12) . The CdtB subunit is a homolog of mammalian type I DNase (7, 12) , and DNase activity associated with CdtB is required for biological activity. Several reports now document that chromosomal DNA is the target of CDT action (3, 4, 8, 11) . Following cellular entry by clathrin-dependent receptor-mediated endocytosis, CDT-containing vesicles fuse with downstream compartments involving sites within the Golgi (2) . Once free of the Golgi, nuclear translocation of CdtB is mediated by nuclear localizing sequences found at the carboxy-terminal end of Escherichia coli CdtB-II (CdtB-II Ec ) (16) and near the amino-terminal end of the CdtB of Actinobacillus actinomycetemcomitans (CdtB Aa ) (18) . CdtB-dependent chromosomal strand breakage triggers DNA damage-dependent mitotic arrest and/or apoptosis (3, 4, 7, 8, (10) (11) (12) .
Accumulating evidence suggests that CdtA and/or CdtC is responsible for the binding and/or internalization of the CDT holotoxin. Deng and Hansen previously reported that the CdtA and CdtC subunits of Haemophilis ducreyi (CdtA Hd and CdtC Hd , respectively) form a complex that binds to the HeLa cell surface and blocks subsequent intoxication by CDT holotoxin (5) . Unlike the CdtAC heterodimer, individual CdtA Hd and CdtC Hd subunits failed to block the action of holotoxin, suggesting that the CdtAC heterodimer is the functional cell surface-binding component of CDT (5) . Recently, Lee et al. demonstrated that CdtA and CdtC of C. jejuni (CdtA Cj and CdtC Cj , respectively) bound independently to HeLa cells and exhibited competitive binding for one another, suggesting that these subunits bind to the same cell surface structure (14) .
Competitive binding similar to that observed by Lee et al. (14) was also observed for CdtA-II Ec and CdtC-II Ec (16) . Unlike CdtA-II Ec and CdtC-II Ec , CdtB-II Ec does not bind the cell surface except in the presence of both CdtA-II Ec and CdtC-II Ec (16) . Taken together, these data support the hypothesis put forth by Lara-Tejero and Galan (13) that CDT is an AB type toxin in which CdtB is the active A component and CdtA and CdtC comprise the B (binding) component. Recent X-ray diffraction and three-dimensional structure modeling of the H. ducreyi CDT holotoxin suggests that CdtA Hd and CdtC Hd are ricin B chain-like lectin molecules that associate to form a scaffold for CdtB Hd association and a binding domain for the cell surface (17) . This study was originated to examine the role that CdtA-II Ec and CdtC-II Ec play in CDT binding and intoxication and to characterize the interaction of these subunits with the cell surface. We report here that cell surface carbohydrates play a key role in CDT subunit binding and subsequent intoxication.
HeLa cells in 1 ml of PBS. For samples containing multiple subunit combinations, the subunits were combined and allowed to incubate for 30 min at room temperature prior to the addition of HeLa cells. Following 1.5 h of incubation, the HeLa cells were washed twice in cold PBS to remove unbound CDT subunits and then incubated with either anti-CdtA-II Ec (1:1,000), anti-CdtB-II Ec (1:1,000), or anti-CdtC-II Ec (1:5,000) antibodies (16) for 1 h on ice. Following this incubation, cells were washed free of unbound antibody and then incubated for 1 h on ice with Alexa 488-conjugated chicken anti-rabbit immunoglobulin G (IgG; 1:1,000) (Molecular Probes, Eugene, Oreg.). Fluorescently labeled cells were then analyzed by flow cytometry. For lectin interference experiments, HeLa cells (5 ϫ 10 5 ) suspended in PBS were incubated with 100 g of the various lectins (described below) for 1 h prior to the addition of the CDT subunits. Following the addition of CDT subunits, binding was assessed by flow cytometry. A single population of cells, identified by forward-and side-scatter emission, was analyzed for fluorescence intensity on the fluorescein isothiocyanate emission channel of a FACSCalibur flow cytometer (BD Biosciences). Background was set with a cell suspension of approximately 10 6 cells per ml that were incubated with primary and secondary antibody but without the addition of CDT subunits. Gain and voltage settings were adjusted to position the background (control) population within in the first decade of fluorescence emission. For each experiment, a minimum of 10 4 cellular events were recorded. Carbohydrate-and lectin-mediated inhibition of CDT activity. Fucose, lactose, ovalbumin, mannose, N-acetylgalactosamine (GalNAc), N-acetylglucosamine (GlcNAc), fetuin, asialofetuin, bovine submaxillary mucin (BSM), ␣ 1 -glycoprotein, thyroglobulin, and transferrin receptor were purchased from Sigma Aldridge. The following lectins were purchased from EY Laboratories (San Mateo, Calif.): EEA, ECA, AAA, SNA-I, STA, UEA-I, GNA, NPA, ConA, CSA, WGA, MPA, and SBA. (For definitions of the lectin abbreviations, see Table 2 .) For carbohydrate inhibition experiments, 3 EDs of native CDT holotoxin was combined with various concentrations of sugars or glycoproteins (dissolved in PBS) in a total volume of 1 ml. After 1 h of incubation at room temperature, the holotoxin-sugar or holotoxin-glycoprotein mixtures were added to 2 ϫ 10 5 HeLa cells in six-well plates and incubated at 37°C for 20 min. The samples were washed twice with 5 ml of PBS to remove unbound toxin. Fresh DMEM was added to the cells that were then incubated for 24 h at 37°C in atmosphere containing 5% CO 2 . Cell cycle distribution analysis was performed as described above.
For lectin inhibition experiments, individual lectins (100 g) were added to 2 ϫ 10 5 HeLa cells in six-well plates and incubated for 1 h at room temperature. Unbound lectins were washed away with two 5-ml PBS washes. Following removal of unbound lectins, 3 EDs of CDT holotoxin were added to the lectintreated cells, which were further incubated for 20 min at 37°C in atmosphere containing 5% CO 2 . The treated cells were washed twice with PBS to remove unbound toxin and suspended in 5 ml of complete DMEM followed by plating in 100-mm-diameter culture dishes. After 24 h of incubation at 37°C in atmosphere containing 5% CO 2 , cell cycle distribution analysis was performed as described above.
Binding of CdtA-II Ec and CdtC-II Ec to immobilized carbohydrates and glycoproteins. Agarose bead matrices coupled with lactose, mannose, fucose, GalNAc, GlcNAc, fetuin, thyroglobulin, and BSM were obtained from EY Laboratories. Binding assays were performed in PBS with 25 g of either CdtA-II Ec or CdtC-II Ec and 100 g of the carbohydrate gel in a final volume of 300 l. Samples were mixed on a tube rotator at 4°C for 1.5 h. Following incubation, the tubes were centrifuged at 4,000 ϫ g for 5 min at 4°C. The supernatant fraction was removed, and the pellets were washed twice with 1 ml of ice-cold PBS. The pellets were suspended in 300 l of sodium dodecyl sulfate (SDS) loading buffer and boiled, and aliquots were loaded on a 12% polyacrylamide gel and separated by SDS-polyacrylamide gel electrophoresis (PAGE). The separated proteins were transferred to polyvinylidene difluoride (PVDF) membranes by electroblotting, blocked with 5% skim milk, and incubated for 2 h with anti-CdtA-II Ec , anti-CdtB-II Ec , or anti-CdtC-II Ec antibodies. Following incubation and subsequent washing to remove excess primary antibody, the PVDF membranes were incubated with alkaline phosphatase-conjugated goat anti-rabbit IgG (Bio-Rad, Hercules, Calif.), washed to remove excess secondary antibody, and then developed with 5-bromo-4chloro-3-indolyl phosphate and nitroblue tetrazolium (BioRad).
RESULTS
Binding of CDT subunits to HeLa cells. Several lines of evidence implicate CdtB as the biologically active CDT subunit. CdtB alone, however, is not cytotoxic unless introduced into the cell by microinjection, electroporation, or expression from a transgene construct. The normal route for triggering the cytolethal activity of CDT requires the presence of all three CDT subunits. Recent reports indicate that CdtA and CdtC are the binding subunits of the CDT holotoxin (5, 14, 16) . These data are supported by structural analysis of the CDT Hd holotoxin, indicating that CdtA Hd and CdtC Hd possess structural folds that resemble those of the ricin B chain (17) . To investigate the association of CDT subunits to HeLa cells, we developed a flow cytometry-based binding assay modeled after a previous study by Warner et al. (26) . In this assay, live, unfixed HeLa cells are incubated with the CDT subunits, either alone or in combination. Cells are then incubated with the appropriate primary antibody followed by Alexa 488-conjugated secondary antibody and examined by flow cytometry. A subsequent increase in the surface fluorescence intensity above background is indicative of subunit binding. Cells incubated with CdtA-II Ec or CdtC-II Ec alone displayed an approximate 10-fold increase in fluorescence above the background (Fig. 1A and C). The background cell population was represented by control cells incubated in the presence of primary and secondary antibody but without CDT subunits ( Fig. 1A and C) . The levels of binding, or fluorescence intensity, observed with either CdtA-II Ec or CdtC-II Ec alone were assigned arbitrary scores of 3ϩ, as shown to the right of Fig. 1A and C, respectively. In the case of the CdtA-II Ec binding, fluorescence was decreased when an equimolar amount of CdtC-II Ec was included in the reaction mixture (Fig. 1A) . The same pattern was observed with the binding of CdtC-II Ec in the presence of CdtA-II Ec (Fig. 1C) . When the binding of CdtA-II Ec was examined in the presence of CdtB-II Ec , the results were the same as those observed with CdtA-II Ec alone (binding pattern shown to the right of Fig. 1A ). When the binding of CdtA-II Ec was examined in the presence of CdtB-II Ec and CdtC-II Ec , the pattern was identical to that of CdtA-II Ec in the presence of CdtC-II Ec (binding pattern to the right of Fig. 1A ): that is to say, the fluorescence intensity signal for CdtA-II Ec was reduced to the 2ϩ level and CdtB-II Ec had no influence on the binding of CdtA-II Ec . These results were identical to those observed for the binding of CdtC-II Ec in the presence of CdtA-II Ec and/or CdtB-II Ec (binding pattern to the right of Fig. 1C ). These observations suggested that CdtA-II Ec and CdtC-II Ec compete for the same binding site on HeLa cells. By comparison to the cell surface binding capacity of CdtA-II Ec and CdtC-II Ec , CdtB-II Ec bound poorly, if at all, to HeLa cells in the absence of CdtA-II Ec and CdtC-II Ec (Fig. 1B) . The presence of either CdtA-II Ec or CdtC-II Ec alone had no influence on CdtB-II Ec binding; however, in the presence of both CdtA-II Ec and CdtC-II Ec subunits, the cell surface binding of CdtB-II Ec was equivalent to that of CdtA-II Ec and CdtC-II Ec ( (Fig. 2) . The bold black histograms represent the binding of CdtA-II Ec and CdtC-II Ec individually, whereas, as before, the gray areas represent the background fluorescence of cells incubated with primary and secondary antibodies in the absence of CDT subunits (Fig. 2 ). In the case of CdtA-II Ec binding, the presence of one-, two-, and fourfold molar excess of CdtC-II Ec in the binding reaction (denoted by dashed gray histograms) steadily decreased the fluorescence intensity to the level of the background (Fig. 2) . Identical results were obtained for the binding of CdtC-II Ec ; that is, increasing amounts of CdtA-II Ec in the reaction mixture re- To further assess the specific function of CdtA-II Ec and CdtC-II Ec , PSI-BLAST analysis was performed on these protein sequences in an attempt to infer functionality based on sequence similarity. Results of a PSI-BLAST search suggested that CdtA-II-II Ec is related to a number of carbohydrate-binding proteins with either galactose or mannose specificity, including ricin B chain, abrin B chain, mistletoe lectin I B chain, and nigrin B chain. In addition, CdtA-II Ec displayed apparent similarity to carbohydrate-specific enzymes, including N-acetylgalactosaminyltransferase, ␤-mannase, xylanase, and ␣-galactosidase. All of the lectins and enzymes having similarity to CdtA-II Ec had final E-values of less than 1e
Ϫ24 . These data inferred that CdtA-II Ec may function as a carbohydrate-binding protein, the target for which may be a cell surface structure. The result of a PSI-BLAST analysis of CdtC-II Ec was less conclusive than that with CdtA-II Ec . After the final PSI-BLAST iteration, proteins identified with significant similarity to CdtC-II Ec were the CdtC and CdtA proteins from other bacterial species. Early iterations of the CdtC-II Ec PSI-BLAST analysis resulted in the same list of lectins and carbohydrate-modifying enzymes present in the final search analysis for CdtA-II Ec . These observations suggest that CdtA-II Ec and CdtC-II Ec may have a similar structural fold and/or the same function.
Glycoproteins but not simple sugars inhibit CDT activity. Based on the PSI-BLAST results for CdtA-II Ec and CdtC-II Ec and X-ray diffraction analysis of CDT holotoxin (17) , it is reasonable to speculate that CdtA-II Ec and CdtC-II Ec bind to carbohydrate-containing receptors on the target cell surface. In this set of experiments, we examined the effect of various simple sugars and glycoproteins on the toxicity of CDT. CDT was preincubated with individual simple sugars or glycoproteins before the addition to HeLa cells for a brief exposure. The ligands tested were lactose, mannose, fucose, GalNAc, GlcNAc, fetuin, asialofetuin, thyroglobulin, ovalbumin, ␣ 1 -glycoprotein, and transferrin receptor. Following preincubation of CDT with blocking sugars and glycoproteins, the mixture was added to HeLa cells and toxicity was assessed by an examination of the cell cycle distribution of treated and untreated cells following 24 h of incubation (Materials and Methods). None of the simple sugars tested inhibited CDT action at doses as high as 1 mg/ml (Table 1 ). In contrast, thyroglobulin, BSM, and, ␣ 1 -glycoprotein inhibited the effects of CDT, with various half-maximal inhibitory concentrations ranging from 75 to 550 g/ml (Table 1) . Thyroglobulin, the strongest inhibitor of CDT activity, resulted in a 50% decrease in toxin activity at a dose of 75 g/ml. BSM and ␣ 1 -glycoprotein blocked CDT activity by 50% at concentrations of 350 and 550 g/ml, respectively (Table 1 ). These data suggested that complex carbohydrates, such as those on glycoproteins, may inhibit CDT to immobilized sugar and sugar-containing ligands was assessed with the following sugar-or glycoprotein-conjugated agarose beads: lactose, mannose, fucose, GalNAc, GlcNAc, fetuin, thyroglobulin, and BSM. CdtA-II Ec and CdtC-II Ec were incubated with the carbohydrate-or glycoprotein-conjugated matrices, which were subsequently washed free of unbound CDT subunits. The gel matrices were then prepared for SDS-PAGE analysis, and CDT subunit binding was assessed by Western blot analysis. CdtA-II Ec and CdtC-II Ec bound the same set of ligands, including thyroglobulin, fetuin, and fucose (Fig. 3A) To a lesser extent, CdtA-II Ec and CdtC-II Ec also bound to GalNAc-and GlcNAc-agarose (Fig. 3A) . Binding of CdtA-II Ec and CdtC-II Ec to the unmodified agarose matrix was negligible, as was the binding of these subunits to mannose and lactose (Fig. 3A) .
Fetuin and thyroglobulin are glycoproteins containing both N-and O-linked complex carbohydrates (21, 27) . In addition, the carbohydrate moieties on these glycoproteins may or may not contain terminal sialic acid residues (21, 27) . In an attempt to identify the linkage specificity of the carbohydrate moiety bound by CdtA-II Ec and CdtC-II Ec , fetuin-and thyroglobulincoupled agarose matrices were subjected to various enzyme pretreatments prior to incubation with the CDT subunits. The binding of CdtA-II Ec and CdtC-II Ec to fetuin-and thyroglobulin-coupled matrices was completely abolished by pretreatment with PNGase F to remove N-linked sugars (Fig. 3B) . Pretreatment of the glycoprotein-conjugated matrices with Oglycosidase or neuraminidase to remove O-linked sugars and sialic acid residues, respectively, had no effect on CdtA-II Ec and CdtC-II Ec binding (not shown).
N-linked sugars on the HeLa cell surface mediate CDTdependent intoxication. A hallmark of CDT action is disruption of cell cycle progression. Histograms depicting DNA content of HeLa cell following various treatments are shown in Fig. 4 . Cells in G 0 or G 1 occupy the left-most population of cells in each histogram representing a DNA content of 2N (Fig. 4) . Cells at the G 2 /M transition of the cell cycle possess 4N DNA content and thus occupy the right-most peak of each histogram (Fig. 4) . Compared to untreated HeLa cells (Fig. 4) , cells treated with CDT accumulated at the G 2 /M transition of the cell cycle (Fig. 4) . To determine whether an interaction of CDT with cell surface carbohydrates was necessary for cellular intoxication, we first removed or prevented the formation of Nand O-linked surface glycan structures on HeLa cells prior to treatment with CDT. Treatment of HeLa cells with benzylGalNAc, an inhibitor of O-linked oligosaccharide glycoprotein attachments, had no effect on subsequent intoxication (Fig. 4) . Likewise, pretreatment of cells with O-glycosidase to remove O-linked carbohydrate structures had no effect on subsequent CDT intoxication (Fig. 4) . In contrast to these observations, cells pretreated with tunicamycin to block the surface expression of N-glycosylation completely blocked the action of CDT (Fig. 4) . Likewise, treatment of HeLa cells with PNGase F to remove surface-N-linked oligosaccharides also blocked subsequent CDT intoxication (Fig. 4) . Together, these data suggest that HeLa cells bear N-linked surface carbohydrate moieties involved in CDT intoxication. Presumably, the N-linked sugar residues are responsible for CDT binding to the HeLa cell surface.
In preliminary experiments, we noted that pretreatment of HeLa cells with neuraminidase to remove exposed sialic acid residues did not appear to inhibit CDT action. Instead, the data were suggested that neuraminidase pretreatment may enhance CDT activity. To verify this, HeLa cells were either pretreated, or not, with neuraminidase to remove terminal sialic acid residues from surface glycoproteins and glycolipids and then treated with 1 ED of CDT. By definition, 1 ED of CDT is that amount which induces a 50% G 2 /M cell cycle block in 24 h (Materials and Methods). As expected, approximately 50% of the CDT-treated cells not pretreated with neuraminidase were blocked at the G 2 /M transition (Fig. 4) . Neuraminidase pretreatment followed by 1 ED of CDT, however, consistently resulted in Ͼ95% of the cells blocked at the G 2 /M interface (Fig. 4) . Treatment with neuraminidase alone had no effect on the cell cycle distribution of HeLa cells (not shown).
Several carbohydrate-binding proteins identified by PSI-BLAST analysis as having similarity to CdtA-II Ec and CdtC-II Ec had binding specificities of galactose and/or mannose oligosaccharides. We examined the effect of CDT on HeLa cells following pretreatment with endo-␤-N-acetylglucosaminidase H (endoH) and ␣-or ␤-galactosidase for removal of mannose ) and CdtC-II Ec (lower panels) with various sugars and glycoproteins coupled to agarose matrices, the beads were washed, eluted by boiling in SDS-PAGE loading buffer, and subjected to SDS-PAGE and Western blot analysis with homologous antibodies to CdtA-II Ec or CdtC-II Ec . The sugars and glycoproteins tested in panel A were as follows: unmodified agarose matrix, thyroglobulin (Thyroglob.), mannose, fetuin, GlcNAc, GalNAc, fucose, and lactose. Binding of CdtA-II Ec and CdtC-II Ec to PNGase F-treated fetuin and PNGase F-treated thyroglobulin was also examined (B).
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on November 7, 2017 by guest http://iai.asm.org/ and galactose residues, respectively. These pretreatments had no affect on the subsequent action of CDT (not shown).
Lectins block CDT activity on HeLa cells.
In an attempt to define the cell surface carbohydrates recognized by CDT, HeLa cells were pretreated with lectins of known carbohydrate specificity and then assessed for sensitivity to CDT. Of the lectins tested (Table 2) , EEA was the most effective in consistently blocking CDT activity. Other lectins that reduced CDT activity were AAA, SNA-I, STA, UEA-I, GNA, and NPA (Table 2) . CDT activity on HeLa cells was not blocked following pretreatment with ECA, ConA, CSA, WGA, MPA, and SBA. The carbohydrate specificity for EEA is Gal (␣1,3) [fuc(␣1,2)]Gal. Of the lectins that partially blocked CDT activity, the carbohydrate specificities are as follows: ␣-L-fucose, UEA-I; ␣-L-fucose, AAA; NeuNAc(␣2,6)GalNAc or lactose, SNA-I; ␤(1,4)GlcNAc oligomers, STA; ␣-D-mannose, NPA; and mannose, GNA ( Table 2 ). These data suggest that oligosaccharides containing fucose, galactose, and/or mannose may be responsible for the cell surface binding of CDT.
Effect The requirement for both CdtA-II Ec and CdtC-II Ec in CDT intoxication coupled with the lack of binding of CdtB-II Ec to target cells in the absence of CdtA-II Ec and CdtC-II Ec is supported by the proposed model for the three-dimensional structure of the H. ducreyi holotoxin (17) . The proposed structural model for the CDT Hd holotoxin suggests that the CdtA Hd and CdtC Hd subunits form a dimer with two functional faces (17) . One CdtAC face binds the cell surface, while the other CdtAC Hd face binds CdtB Hd . Of particular interest to this report is the proposed cell surface-binding domain of the CdtA Hd -CdtC Hd dimer. The CdtA Hd domain of the proposed cell surface binding face formed by the CdtAC Hd contact region contains a patch of aromatic residues highly conserved among CdtAs of all species of origin. Mutagenesis of four conserved residues (W91G, W98G, W100G, and Y102A) eliminated toxicity but preserved the ability of the CdtA Hd mutant to form a holotoxin structure with CdtB Hd and CdtC Hd (17) . The authors propose that this region defines the cell surfacebinding of CDT Hd . It is interesting to note that these conserved residues are all contained within an in-frame 43-amino-acid C. jejuni CdtA deletion mutant prepared by Lee et al. (14) . The CdtA Cj deletion mutant still bound HeLa cells but was unable to participate in the formation of CDT holotoxin and thus was inactive. In addition, the CdtA Cj deletion mutant competed with CDT holotoxin for cell surface binding. These authors suggested that residues contained within the 43-amino-acid deletion were involved in the association of CdtA Cj and CdtC Cj (14) . The aromatic patch identified on the surface of CdtA Hd by structural analysis fits a projected model for a carbohydratebinding domain on a globular protein (20) . The amino acids defining the binding activity of CdtA and CdtC, as well as the CdtAC dimer, although presently unknown, will undoubtedly lie within the surface area of the CdtAC contact region as defined for the H. ducreyi CDT by Nesic and Stebbins (17) .
In this report, we examined the binding of CdtA-II Ec and CdtC-II Ec to HeLa cells, using a flow cytometry-based binding b CDT activity was assessed as described in Materials and Methods. A score of ϩϩ indicated that activity was completely inhibited to the level of the control, which received no lectin pretreatment. A score of ϩ indicated that activity was reduced consistently from Ͼ95% of cells blocked in G 2 /M to Ͻ50% of cells blocked in G 2 /M. Identical results were obtained in each of three experiments with each lectin tested.
c Inhibition of binding was as described in the legend to (27) . Other confirmed N-linkage sites are coupled to a mixture of high mannose, galactose, and glucosamine. Nlinked sugars on fetuin are highly fucosylated and carry the fucose-and galactose-containing Lewis X or asialo-Lewis X epitopes (21) . CdtA-II Ec and CdtC-II Ec both bound efficiently to each of these glycoproteins. The increase in CDT activity for HeLa cells observed following treatment of cells with neuraminidase suggests that removal of terminal sialic acid residues exposes additional binding sites for CdtA-II Ec and CdtC-II Ec .
Release of the N-linked sugars from thyroglobulin and fetuin completely abolished their binding capacity for CdtA-II Ec and CdtC-II Ec . However, O-linked sugars were apparently not involved in CDT subunit binding, since removal of these linkages from the model glycoproteins had no effect on CdtA-II Ec or CdtC-II Ec binding. In addition to these data, treatment of HeLa cells with PNGase F to remove N-linked glycan structures or tunicamycin to prevent N glycosylation completely inhibited subsequent CDT intoxication. Treatments to block, or remove, O-linked sugars from HeLa cells had no effect on subsequent toxicity, suggesting again that O-linked sugars are not involved in the association of CDT with target cells. Lectins with a number of different specificities including fucose, galactose, mannose GalNAc, and GlcNAc reduced or diminished subsequent CDT intoxication. These results were in contrast to the subunit blocking experiments, in which only three lectins, AAA, EEA, and UEA, blocked the binding of CdtA-II Ec and CdtC-II Ec to HeLa cells. This apparent discrepancy may indicate that lectins that block CDT activity, but do not block binding of individual CdtA-II Ec and CdtC-II Ec subunits, sterically interfere with holotoxin binding. The common ligand specificity of the three lectins that block individual subunits binding is fucose.
These data, coupled with the results of our lectin blocking experiments suggest that CdtA-II Ec and CdtC-II Ec bind Nlinked fucose containing complex carbohydrates on the HeLa cell surface. A determination of the specific limits of the carbohydrate-binding specificity of CdtA-II Ec and CdtC-II Ec awaits verification by additional carbohydrate binding analyses. We are presently attempting to refine the carbohydrate specificity of the cell surface ligands bound by CdtA-II Ec and CdtC-II Ec and define the subunit residues responsible for the carbohydrate-binding activity described in this report.
